Literature DB >> 11821877

MMP inhibitors: glimmers of hope amidst clinical failures.

Alan Dove.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11821877     DOI: 10.1038/nm0202-95

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

2.  Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis.

Authors:  Omar Ladhani; Cristina Sánchez-Martinez; Jose L Orgaz; Benilde Jimenez; Olga V Volpert
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

3.  Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.

Authors:  Akhilesh Kumar; Shephali Bhatnagar; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

4.  Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction.

Authors:  Rogelio Zamilpa; Elizabeth F Lopez; Ying Ann Chiao; Qiuxia Dai; Gladys P Escobar; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

Review 5.  The role of matrix metalloproteinases in cystic fibrosis lung disease.

Authors:  A Gaggar; A Hector; P E Bratcher; M A Mall; M Griese; D Hartl
Journal:  Eur Respir J       Date:  2011-01-13       Impact factor: 16.671

6.  Analysis of the MMP-dependent and independent functions of tissue inhibitor of metalloproteinase-2 on the invasiveness of breast cancer cells.

Authors:  Logan A Walsh; Mario A Cepeda; Sashko Damjanovski
Journal:  J Cell Commun Signal       Date:  2012-01-08       Impact factor: 5.782

7.  Vaccines targeting the neovasculature of tumors.

Authors:  Agata Matejuk; Qixin Leng; Szu-Ting Chou; Archibald J Mixson
Journal:  Vasc Cell       Date:  2011-03-08

Review 8.  Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.

Authors:  Yuji Ogura; Marjan M Tajrishi; Shuichi Sato; Sajedah M Hindi; Ashok Kumar
Journal:  Front Cell Dev Biol       Date:  2014-04-01

Review 9.  Heparanase and the hallmarks of cancer.

Authors:  Krishnath M Jayatilleke; Mark D Hulett
Journal:  J Transl Med       Date:  2020-11-30       Impact factor: 5.531

10.  Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma.

Authors:  Hoshino Daisuke; Hisamori Kato; Kazuhiro Fukumura; Akila Mayeda; Yohei Miyagi; Motoharu Seiki; Naohiko Koshikawa
Journal:  Cancer Sci       Date:  2021-11-05       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.